Skip to main content
AllAfrica

AllAfrica

Newspaper | International | Centre

Engagement Insights

0.39 score
69
Discussions
1
Participants
1
Total Votes
668
Articles

Discussions from AllAfrica

Healthcare

What are the important things to consider when creating treatment facilities and vaccine trials for Ebola in the DR Congo?

The DR Congo is set to open its largest Ebola treatment facility. Construction is nearing completion as health authorities race to contain an outbreak that the World Health Organization has described as intensifying at an "exceptional" pace. As of July 30, the WHO reported 3,605 confirmed Ebola cases and 1,587 deaths in the DR Congo. Officials hope the expanded treatment capacity will strengthen response efforts and improve care for patients as the outbreak continues to spread

France
Join Discussion
Geopolitics

What can be done to improve safety and stability in northern Mali amidst ongoing rebel attacks?

The Malian army said Saturday that several northern towns, including Gao and Sévaré, were targeted by rebels. The statement came as a rebel group announced a new offensive to capture a town in the country's north. Andrew Lebovich, a research fellow at Clingendael's Conflict Research Unit, said some of the targets were intended more as "diversions" than as primary objectives, unlike strategically important towns such as Anefis

France
Join Discussion
Politics

How do different views on media regulation and bail policies affect democracy in Uganda?

[Nile Post] The Uganda Law Society (ULS) has called on the Judiciary to publicly and unequivocally condemn President Yoweri Museveni's remarks on the pending treason trial of veteran opposition leader and four-time presidential candidate Dr. Kizza Besigye, as well as his renewed push to abolish bail, describing the comments as unconstitutional executive interference in the administration of justice

International
Join Discussion
Healthcare

What are the potential benefits and challenges of using a new Ebola test in Africa?

Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL). The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately. WHO’s EUL procedure assesses the quality, safety and performance of essential health products based on the available evidence, while ensuring they meet minimum international standards and address the needs of low- and middle-income countries. Through this mechanism, WHO aims to accelerate access to reliable diagnostic tools for early case detection, timely clinical care, disease surveillance and effective outbreak response. The EUL also supports United Nations procurement agencies and governments in making informed decisions about the procurement and use of these products in public health emergency settings. "Public health emergencies require not only speed, but also confidence that the health products being used meet standards for quality, safety and performance," said Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data. "During a fast-moving outbreak, timely access to quality-assured diagnostic tests can make a critical difference in containing transmission. Through this Emergency Use Listing, WHO is helping countries access trusted diagnostic tools more rapidly so that they can respond more effectively.” On 17 May 2026, WHO Director-General Dr Tedros Adhanom Ghebreyesus declared a public health emergency of international concern over the outbreak of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo, with cases in Uganda. Less than two weeks later, WHO launched a call for manufacturers of IVDs for Bundibugyo virus to submit Expressions of Interest for Emergency Use Listing. The listing comes at a critical time as countries respond to the largest recorded outbreak of Ebola disease caused by BDBV, which continu

Global
Join Discussion